“A revolutionary new cancer treatment paradigm that captures cancer heterogeneity in time and space in patients receiving active treatment, thereby transforming the way the world treats cancer to accelerate cures for all. By leveraging Cambridge’s world-leading expertise in cancer genomics, liquid biopsies, molecular imaging and 3D tumour mapping, we will generate longitudinal Data Streams that simultaneously report the functional biology of tumours among cancer patients receiving active treatment. The continual, iterative and integrated analysis of these complementary and complex data streams – made possible by advanced machine learning and other computational approaches – will enable a new decision matrix for optimal cancer treatment selection and improved chance of cure.”
Can every patient benefit from Integrated Cancer Medicine?
Currently we are in the proof of concept phase of this novel paradigm and only patients on one of our prospective clinical trials will be included in the data analysis aspects at this stage.
If you are interested in collaborating with us please reach out to us via icm@crukcambridgecentre.org.uk. Our MFICM Executive Team assesses all collaboration requests to ensure aligned interests and how specific expertise fits with expertise already present in the institute.
There are currently no job opportunities in the MFICM.
Click here to see the University of Cambridge job opportunities
Connect with us
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.